What is ABUS's P/E ratio?

ARBUTUS BIOPHARMA CORP (ABUS) currently trades at a P/E ratio of 4.87.

ARBUTUS BIOPHARMA CORP reports a Return on Equity (ROE) of 61.77%.

What is ABUS's dividend yield?

ARBUTUS BIOPHARMA CORP offers a dividend yield of 0.00%.

What is ABUS's Deepscope Quality Score?

Deepscope rates ABUS's overall financial quality at 69 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ABUS?

Deepscope's AI Timing Score for ABUS is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ABUS belong to?

ARBUTUS BIOPHARMA CORP is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

หุ้น ABUS (NASDAQ) | ARBUTUS BIOPHARMA CORP – วิเคราะห์โดย Deepscope

Stock Check ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.
(Price: 2026-06-05 | FS: 2026-03-31)

ABUS

ARBUTUS BIOPHARMA CORP

US:NASDAQ STOCK Healthcare >> Biotechnology News 93

USD 4.25

-0.10 (-2.30%) Day Change

Watchlist Portfolio Compare Chart

4.87

P/E

0.00

D/E

61.8%

ROE

58.0%

ROA

0.00%

Div Yield

-0.20

PEG

ARBUTUS BIOPHARMA CORP
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 4.25 Price -0.10 (-2.30%) Day Change	NEWS SCORE: 93

ABUS มีคุณภาพโดยรวมพอใช้ ( คะแนนปัจจัยพื้นฐาน = 69) และ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

Loading chart...

69 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: อัตราเร่งของการเติบโตของอัตราผลตอบแทนผู้ถือหุ้น (ROE) ต่ำกว่าเกณฑ์
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ในอดีต ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตราผลตอบแทนสินทรัพย์ (ROA) ต่ำกว่าเกณฑ์
อัตรากำไรสุทธิในอดีต ค่อนข้างต่ำ

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ยังไม่ดีนัก สุขภาพทางการเงิน ไม่ดี และ ประสิทธิภาพการทำกำไร พอใช้ , ...

ปัจจัยทางคุณภาพ

51%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	93
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	4.25
PBV / Sector	3.23 / 4.63
Earning Per Share	0.81

PE / Sector	4.87 / 17.43 GREAT
PEG or PE/Growth / Sector	-0.20 / 0.53
Average 1M Daily Value	6.51 M
Average 1W Daily Value	5.34 M GREAT

ปัจจัยทางเทคนิค

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

สุขภาพทางการเงิน

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ประสิทธิภาพการทำกำไร

68%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	83.95 / 449.48 GREAT
NPM Average (%) / Sector	-373.31 / -1,506.49
NPM Change Average (%) / Sector	23.36 / 4,940.99 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	57.99 / 30.58 GREAT
ROA Average (%) / Sector	-23.30 / -347.17
ROA Change Average (%) / Sector	-62.48 / 5,125.52
ROE (%) / Sector	61.77 / -3.58 GREAT
ROE Average (%) / Sector	-34.65 / 40.65
ROE Change Average (%) / Sector	-60.10 / 2,109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

ผลตอบแทนต่อผู้ถือหุ้น

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.17

รายละเอียดการจดทะเบียน

Analyze Date	2026-06-06 09:08:25
Symbol	ABUS
Name	ARBUTUS BIOPHARMA CORP
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	197.54 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	839.54 / 8,857.28

ข่าว, ประมาณการ, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 701 Veterans Circle, Warminster, PA, United States, 18974

Phone: 267 469 0914

Website: https://www.arbutusbio.com

Sector: Healthcare >> Biotechnology

Description: Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients' HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.